Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes.
Saved in:
| Title: | Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes. |
|---|---|
| Authors: | Shteinman ER; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Attrill GH; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Maher NG; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Gnana K; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Addala V; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Mao Y; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Palendira U; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Conway JW; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Waddell N; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia., Hayward NK; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Pearson JV; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; Mater Hospital, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au. |
| Source: | Genome medicine [Genome Med] 2026 May 26; Vol. 18 (1). Date of Electronic Publication: 2026 May 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42186061 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shteinman+ER%22">Shteinman ER</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Attrill+GH%22">Attrill GH</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Maher+NG%22">Maher NG</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Gnana+K%22">Gnana K</searchLink>; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Addala+V%22">Addala V</searchLink>; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Mao+Y%22">Mao Y</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Palendira+U%22">Palendira U</searchLink>; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Conway+JW%22">Conway JW</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Colebatch+AJ%22">Colebatch AJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Waddell+N%22">Waddell N</searchLink>; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Hayward+NK%22">Hayward NK</searchLink>; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Pearson+JV%22">Pearson JV</searchLink>; Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore Hospital, Sydney, NSW, Australia.; Mater Hospital, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Scolyer+RA%22">Scolyer RA</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Wilmott+JS%22">Wilmott JS</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Vergara+IA%22">Vergara IA</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. ismael.vergaracorrea@sydney.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101475844%22">Genome medicine</searchLink> [Genome Med] 2026 May 26; Vol. 18 (1). <i>Date of Electronic Publication: </i>2026 May 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101475844 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-994X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756994X%22">1756994X </searchLink><i>NLM ISO Abbreviation: </i>Genome Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42186061 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13073-026-01673-3 Languages: – Code: eng Text: English Titles: – TitleFull: Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shteinman ER – PersonEntity: Name: NameFull: Attrill GH – PersonEntity: Name: NameFull: Maher NG – PersonEntity: Name: NameFull: Gnana K – PersonEntity: Name: NameFull: Addala V – PersonEntity: Name: NameFull: Mao Y – PersonEntity: Name: NameFull: Palendira U – PersonEntity: Name: NameFull: Conway JW – PersonEntity: Name: NameFull: Colebatch AJ – PersonEntity: Name: NameFull: Waddell N – PersonEntity: Name: NameFull: Hayward NK – PersonEntity: Name: NameFull: Pearson JV – PersonEntity: Name: NameFull: Long GV – PersonEntity: Name: NameFull: Scolyer RA – PersonEntity: Name: NameFull: Wilmott JS – PersonEntity: Name: NameFull: Vergara IA IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 05 Text: 2026 May 26 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1756-994X Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Genome medicine Type: main |
| ResultId | 1 |